Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
According to TW, ABDX is a dog of a company and deserves its drop today. Avacta doesn't.
Not quite true. I emailed my local MP and he telephoned me and we had quite a long chat about Avacta because he gave talks on cancer research. I did emphasise the case for sourcing LFTs from a British company and I think he took it on board.
Wow, you really are a piece of work Ophidian. Yes, I thought that AVA6000 was Affimer based which I admit was a stupid mistake. I have since read up on the subject and realized my error. Now, for Chr1st sake let it go.
Cheers Bella.
Even though I have held AVCT for twelve years, I have obviously got the technicalities of AVA6000 completely wrong so I apologise for that. I'm not going to argue about full stops either.
I was trying to make sense of the AVA6000 trial schedule to see if there could be any indications of the progress achieved that might affect the sp well before the end of the year. The first recipient is suffering with pancreatic cancer which as I understand is notoriously difficult to diagnose until it has got a real hold and that death is more than likely the eventual outcome. So is this trial a "last resort" and if affimers cause problems, the patient would have died anyway? So I wonder, if this patient is the "guineapig" for the very first ever Affimer trial, if further patients are dosed, would that mean that affimers don't cause immediate problems and are relatively safe to continue to use in the trial? Would this news, if published, affect the sp. There are 80 patients in total for the trial so I would have thought that after about 40 patients, affimers should have proved their worth and it would be a case of escalating the dose of Doxorubicin. A simplistic view, I know, but I think the sp could be going up earlier than we think if we are kept up to date with news. If it also means that our trial patients survive, how great would that be?
I think that one drawback with this share is that if they are testing in one growing season there's a long wait for results. Ideally, testing in multiple growing seasons would be useful. Maybe this is happening, I don't know.
What makes me laugh is the kind of abuse that Dr. Alastair Smith gets when things don't go the way this board wants them to go. The £40mil was raised to advance a pipeline of projects and I would imagine that a pipeline of projects takes an awful lot of AL's time. This test probably ranks alongside the office stationary in importance and the real moneyshot will be in the treatment of cancer and replacing antibodies. and as for the arrogant pigs that call Dr. Alastair Smith "Smith" they are beneath contempt. I have huge profits in Avacta because i have been following the company for 11years and knew when to load up, so I am very happy with the way things are going and I'm not bothered by this LFT sideshow as most of you seem to be.
Crumbs, if it reached £20, I could buy a couple of houses, and I expect many others on here could too.
I don’t think that munch box is an amateur at all. In fact he/she is very sensible in selling when satisfied with their profit. I was into VRS and watched £56k of profit gradually drain away and
again with Summerway, although that was only £4.5k. So it’s unwise to mock people with a sound investment strategy. Each to their own.
To be honest, when I first came across the name Plant Healthcare, my first thought was of a tray of healthy looking pansies. I would have thought that a name like Global Agricultural Solutions would have been far more impressive and maybe attracted more attention to a company that I believe has incredible potential and is very cheap at the moment. Still it's a great opportunity to get in at the bottom and build a good position.
Been watching this company for a while, so I bought in this afternoon. Pretty impressive outlook.
My trading account was in joint names with my wife, so the cgt relief was doubled. Over time I've emptied my sipps and trading accounts into Isas, but I suppose some politician will have a go at those like they did with insurance policies.
The picture shows a nasel swab not the cheek as described.
After some years of investing, you get used to watching portfolio drops of £30k-£40k in a short time. Just turn off your pc and do something else.
Just bought a few more and I don’t care what it does today, I’m here for the long term.
Well said Fred. Man after my own heart.
I've been here since 2009 and remember this BB was busy if it got one post per month and the SP was .7p. It will be very gratifying if this does hit the £20-30 mark before I get too old to enjoy the dosh and It will be nice to have a couple of mil in the bank. Congrats to all holders here and thanks to all the super researchers on this board that have confirmed my continuing faith in AS and Avacta. GLA.
Anybody who has watched the Vox interview with Alastair Smith should be completely blown away by the information imparted and should be feeling completely satisfied with their investment.
Thanks for that and yes that does seem to happen to me quite a bit, but I am glad to see this hasn’t happened here.......yet.